DK1965763T3 - Stabile enzympræparater og fremgangsmåder til anvendelse heraf - Google Patents

Stabile enzympræparater og fremgangsmåder til anvendelse heraf Download PDF

Info

Publication number
DK1965763T3
DK1965763T3 DK06821673.8T DK06821673T DK1965763T3 DK 1965763 T3 DK1965763 T3 DK 1965763T3 DK 06821673 T DK06821673 T DK 06821673T DK 1965763 T3 DK1965763 T3 DK 1965763T3
Authority
DK
Denmark
Prior art keywords
enzym
preparations
stable
methods
stable enzym
Prior art date
Application number
DK06821673.8T
Other languages
Danish (da)
English (en)
Inventor
Amihay Freeman
Noa Hadar
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Application granted granted Critical
Publication of DK1965763T3 publication Critical patent/DK1965763T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
DK06821673.8T 2005-12-27 2006-12-27 Stabile enzympræparater og fremgangsmåder til anvendelse heraf DK1965763T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75340005P 2005-12-27 2005-12-27
PCT/IL2006/001492 WO2007074454A2 (en) 2005-12-27 2006-12-27 Stable enzymatic preparations and methods of use thereof

Publications (1)

Publication Number Publication Date
DK1965763T3 true DK1965763T3 (da) 2020-02-10

Family

ID=37943776

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06821673.8T DK1965763T3 (da) 2005-12-27 2006-12-27 Stabile enzympræparater og fremgangsmåder til anvendelse heraf

Country Status (6)

Country Link
US (2) US8197808B2 (https=)
EP (1) EP1965763B1 (https=)
JP (1) JP5435955B2 (https=)
DK (1) DK1965763T3 (https=)
ES (1) ES2763724T3 (https=)
WO (1) WO2007074454A2 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US8197808B2 (en) 2005-12-27 2012-06-12 Ramot At Tel-Aviv University Ltd. Stable enzymatic preparations and methods of use thereof
ATE554769T1 (de) * 2006-12-06 2012-05-15 Cornell Res Foundation Inc Neuromuskuläre blocker mit mittlerer dauer und antagonisten advon
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
CA2727432C (en) 2008-06-12 2016-10-11 Medtronic Xomed, Inc. Method for treating chronic wounds with an extracellular polymeric substance solvating system
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
PL2318035T3 (pl) 2008-07-01 2019-10-31 Curemark Llc Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
KR20170005191A (ko) 2009-01-06 2017-01-11 큐어론 엘엘씨 이. 콜라이에 의한 구강 감염의 치료 또는 예방을 위한 조성물 및 방법
CN102300989B (zh) 2009-01-06 2015-12-09 柯尔朗恩有限责任公司 用于治疗或预防金黄色葡萄球菌感染以及用于根除或减少表面上金黄色葡萄球菌的组合物和方法
EP2226382A1 (en) 2009-03-03 2010-09-08 B.R.A.I.N. Biotechnology Research and Information Network AG Protease for wound conditioning and skin care
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9220700B2 (en) 2009-08-19 2015-12-29 Cornell University Cysteine for physiological injection
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
SG187534A1 (en) 2010-08-29 2013-03-28 Vascode Technologies Ltd A system and methods for multi-tasking in a clientless mobile phone
US8980252B2 (en) 2011-04-21 2015-03-17 Curemark Llc Methods of treatment of schizophrenia
CN107854737B (zh) * 2011-08-31 2021-03-26 凯希特许有限公司 减压治疗与清创系统以及方法
CA2862363C (en) * 2012-02-02 2021-06-08 Joan M. Fallon Enzyme compositions and use thereof for wound healing
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
AU2016340017B2 (en) * 2015-10-14 2023-10-05 Newsouth Innovations Pty Limited Compositions and methods for the treatment of diseases involving mucin
JP6952353B2 (ja) * 2016-01-31 2021-10-20 メディウーンド リミテッド 創傷を治療するためのデブリードマン組成物
BR112018071405A2 (pt) * 2016-04-18 2019-02-05 Mediwound Ltd métodos de debridamento de ferimentos crônicos
AU2018250823A1 (en) 2017-04-10 2019-10-17 Curemark, Llc Compositions for treating addiction
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
EP4251141A4 (en) * 2020-11-25 2024-10-02 Topix Pharmaceuticals, Inc. SCAR TREATMENT COMPOSITION
CN115998690B (zh) * 2022-11-10 2024-07-26 上海泰昶生物技术有限公司 包含免疫球蛋白g降解酶的冻干制剂及其制备工艺

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB913203A (en) * 1958-12-30 1962-12-19 Swift & Co Enzyme formulations for the production of tenderized meat
US3539451A (en) * 1968-05-31 1970-11-10 Castle & Cooke Production of reversibly inactivated papain and ficin
US4307081A (en) * 1974-01-08 1981-12-22 Gerold K. V. Klein Enzyme mixture
US4715899A (en) * 1982-10-21 1987-12-29 Subir Chanda Liquid cleaner containing inactivated protease for protein soiled contact lenses
JPH0449299A (ja) * 1990-06-14 1992-02-18 Tosoh Corp 免疫グロブリンフラグメントの精製法
DE4026591B4 (de) 1990-08-23 2005-08-25 Pleva Gmbh Vorrichtung zur Bestimmung der Beladung von Luft mit Dämpfen
JP2665639B2 (ja) * 1992-01-09 1997-10-22 テーオー食品株式会社 安定化されたチオール蛋白分解酵素を含む焼き肉のタレ
US7364565B2 (en) 2001-07-27 2008-04-29 Ramot At Tel Aviv University Ltd. Controlled enzymatic removal and retrieval of cells
MXPA04004479A (es) * 2001-11-13 2004-08-11 Procter & Gamble Composiciones topicas que contienen enzimas estabilizadas con inhibidores.
US6692726B1 (en) * 2003-02-11 2004-02-17 Colgate Palmolive Company Enzyme containing oral composition having enhanced stability
DE602004020910D1 (de) * 2003-10-10 2009-06-10 Cosmedical Aps Haarwuchshemmung
US8197808B2 (en) 2005-12-27 2012-06-12 Ramot At Tel-Aviv University Ltd. Stable enzymatic preparations and methods of use thereof

Also Published As

Publication number Publication date
ES2763724T3 (es) 2020-05-29
EP1965763B1 (en) 2019-11-06
US8337837B2 (en) 2012-12-25
WO2007074454A2 (en) 2007-07-05
WO2007074454A3 (en) 2007-09-20
JP5435955B2 (ja) 2014-03-05
US8197808B2 (en) 2012-06-12
JP2009521521A (ja) 2009-06-04
US20120114631A1 (en) 2012-05-10
US20090220483A1 (en) 2009-09-03
EP1965763A2 (en) 2008-09-10

Similar Documents

Publication Publication Date Title
DK1965763T3 (da) Stabile enzympræparater og fremgangsmåder til anvendelse heraf
NO2017017I1 (no) umeklinidium og vilanterol
DK2147315T3 (da) Diabetesrelaterede biomarkører og fremgangsmåder til anvendelse deraf
DK1969391T3 (da) Tyndfilm emitter-absorber indretning og fremgangsmåde
DK1877090T3 (da) Trimert ox40-immunoglobulin-fusionsprotein og fremgangsmåder til anvendelse heraf
DK1805312T3 (da) Fremgangsmåder og midler til fremstilling af hyaluronan
DK1844155T3 (da) Sekvensspecifikke serinrekombinaser og fremgangsmåder til anvendelse deraf
EP1895838A4 (en) COMPOSITIONS AND METHODS
IS8204A (is) Tæki og aðferð til að hluta niður
DK1890588T3 (da) Ambulant lægemiddelindretning og fremgangsmåde til kommunikation mellem lægemiddelindretninger
DK1934179T3 (da) Fremgangsmåder og mellemprodukter
DK1954140T3 (da) Glycerollevulinatketaler og deres anvendelse
DK1924577T3 (da) Substituerede benzimidazoler og fremgangsmåder til fremstilling
DK1984344T3 (da) Multicykliske aminosyrederivater og fremgangsmåder til anvendelse heraf
DK2578685T3 (da) Rna indeholende modificerede nukleosider og fremgangsmåder til anvendelse deraf
DK2209375T3 (da) Parp-inhibitorforbindelser, præparater og fremgangsmåder til anvendelse deraf
DK3366283T3 (da) Direkte sammenpresningsformulering og fremgangsmåde
EP1943080A4 (en) METHOD AND APPARATUS FOR BLOW MOLDING WITH STRETCHING
DK1929297T3 (da) Biomarkører for dissemineret sklerose og fremgangsmåder til anvendelse heraf
DK1846445T3 (da) PYY-agonister og anvendelser deraf
DK1894567T3 (da) Ledsagende farmaceutiske midler og anvendelse deraf
DK2390267T3 (da) Stabile og opløselige antistoffer, der hæmmer TNF(alfa)
DK1948852T3 (da) Hovedelektrode og fremgangsmåde til dannelse af hovedelektroden
DK2038275T3 (da) Ny pyridazinforbindelse og anvendelse heraf
DK2029799T3 (da) Termostabile proteiner og fremgangsmåder til fremstilling og anvendelse heraf